central precocious puberty

临床试验

计划入组 36 人 · 首次发布于 2008 年 10 月 24 日

已完成

NCT07359092

Spexin and Phoenixin-20 in Girls With Central Precocious Puberty

计划入组 143 人 · 首次发布于 2026 年 1 月 22 日

已完成

NCT00660010

Study of Lupron Depot In The Treatment of Central Precocious Puberty

计划入组 55 人 · 首次发布于 2008 年 4 月 17 日

药物

查看全部 194 →

Small Molecule

Approved

Nafarelin(Synarel)

生产企业：Gd searle llc

相关疾病：Central Precocious Puberty (CPP), Endometriosis

C₆₆H₈₃N₁₇O₁₃

Small Molecule

Approved

Leuprolide Acetate(Camcevi, Eligard, Fensolvi, Lupaneta Pack 1-month, Lupron, Lupron Depot-ped, Viadur, Zeulide Depot)

相关疾病：Advanced Prostate Cancer, Anemia，另有 2 项

C₅₉H₈₄N₁₆O₁₂ · Rx

Small Molecule

Approved

Histrelin(Supprelin)

相关疾病：Advanced Prostate Cancer, Central Precocious Puberty (CPP)

C₇₀H₉₄N₁₈O₁₆

机构

查看全部 771 →

Algoma Central Corp

KURASHIKI CENTRAL HOSPITAL

Japan

CENTRAL PACKAGING (S.A.) PTY. LTD.

Australia

资讯

查看全部 4157 →

去年

Foresee Pharmaceuticals Completes Enrollment in Phase 3 Trial for Central Precocious Puberty Treatment

10个月前

Debiopharm Completes Enrollment for First-Ever Yearly Injectable Triptorelin Formulation in Pediatric Central Precocious Puberty Trial

去年

临床试验

Histrelin Subcutaneous Implant in Children With Central Precocious Puberty

Spexin and Phoenixin-20 in Girls With Central Precocious Puberty

Study of Lupron Depot In The Treatment of Central Precocious Puberty

药物

Nafarelin(Synarel)

Leuprolide Acetate(Camcevi, Eligard, Fensolvi, Lupaneta Pack 1-month, Lupron, Lupron Depot-ped, Viadur, Zeulide Depot)

Histrelin(Supprelin)

机构

Algoma Central Corp

KURASHIKI CENTRAL HOSPITAL

CENTRAL PACKAGING (S.A.) PTY. LTD.

资讯

Foresee Pharmaceuticals Completes Enrollment in Phase 3 Trial for Central Precocious Puberty Treatment

Debiopharm Completes Enrollment for First-Ever Yearly Injectable Triptorelin Formulation in Pediatric Central Precocious Puberty Trial

DSMB Endorses Safety of Foresee's CAMCEVI in Pediatric Precocious Puberty Trial